by lythamcorp | Nov 7, 2024 | Healthcare, ImmuCell Corporation, ImmuCell News
Conference Call Scheduled for Thursday, November 14, 2024 at 9:00 AM ETPORTLAND, Maine, Nov. 07, 2024 — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and...
by lythamcorp | Nov 7, 2024 | Healthcare, Trinity Biotech, Trinity Biotech News
DUBLIN, Nov. 07, 2024 — Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that on November 6, 2024, it...
by lythamcorp | Nov 7, 2024 | Healthcare, Modular Medical, Modular Medical News
-Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery- Observed weight loss was 17% at 28 days, a 25% improvement over GLP-1 delivered as basal alone-Findings suggest that pump...
by lythamcorp | Nov 7, 2024 | PolyPid, PolyPid News
PETACH TIKVA, Israel, Nov. 07, 2024 — PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Company’s management will participate in...
by lythamcorp | Nov 7, 2024 | Healthcare, InfuSystem, InfuSystem News
Record Net Revenues of $35.3 million Representing 11% Growth from the Prior Year Net income of $1.8 million, an increase of 162% Adjusted EBITDA (non-GAAP) margin expanded by 2.8% to 22% Reaffirms Full-Year 2024 Guidance ROCHESTER HILLS, Mich. – InfuSystem...